Good Distribution Practices (GDP) adopted by PIC/S
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Good Distribution Practice has now found its way into the Pharmaceutical Inspection Co-Operation Scheme (PIC/S).
Globalisation with longer and more complex supply chains but also counterfeiting problems have been forcing pharmaceutical industry and inspectorates to challenge their current practices. As a consequence, PIC/S - fostering the cooperation established between the participating authorities in the field of inspection and related areas - has now amended its Pharmaceutical Inspection Co-operation Scheme Document defining both Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) as core areas. In the document it is now referred to Good Manufacturing and Distribution Practice (GMDP). Changing over from GDP to GMDP does mean that PIC/S will now also include GDP aspects in its co-operation, harmonisation and training activities.
Source: Pharmaceutical Inspection Co-operation Scheme
Wolfgang Schmitt
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


